BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14405382)

  • 1. Investigation of tumor variants recovered from mice with systemic leukemia (L1210) after extensive therapy with 3',5'-dichloroamethopterin and 3'-bromo-5'-chloroamethopterin.
    HUMPHREYS SR; GOLDIN A
    J Natl Cancer Inst; 1959 Oct; 23():633-53. PubMed ID: 14405382
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.
    VENDITTI JM; SCHRECKER AW; MEAD JA; KLINE I; GOLDIN A
    Cancer Res; 1960 Nov; 20():1451-6. PubMed ID: 13780697
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of orally administered 3', 5'-dichloroamethopterin on formate-C14 incorporation in leukemic mice.
    SCHRECKER AW; MEAD JA; LYNCH MR; VENDITTI JM; GOLDIN A
    Cancer Res; 1960 Nov; 20():1457-61. PubMed ID: 13748581
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined treatment of advanced leukemia (L1210) in mice with amethopterin and 6-mercaptopurine.
    GOLDIN A; HUMPHREYS SR; MANTEL N; VENDITTI JM
    J Natl Cancer Inst; 1956 Nov; 17(5):631-8. PubMed ID: 13377178
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity of mice surviving systemic leukaemia (L1210) to antifolic resistant variants of the disease.
    GOLDIN A; HUMPHREYS SR; CHAPMAN GO; CHIRIGOS MA; VENDITTI JM
    Nature; 1960 Jan; 185():219-21. PubMed ID: 13850658
    [No Abstract]   [Full Text] [Related]  

  • 6. The association of increased dihydrofolate reductase with amethopterin resistance in mouse leukemia.
    FRIEDKIN M; CRAWFORD E; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1962 Jun; 22():600-6. PubMed ID: 13895219
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the management of mouse leukemia (L1210) with antagonists of folic acid.
    GOLDIN A; VENDITTI JM; HUMPHREYS SR; DENNIS D; MANTEL N
    Cancer Res; 1955 Dec; 15(11):742-7. PubMed ID: 13270267
    [No Abstract]   [Full Text] [Related]  

  • 8. THERAPEUTIC AND IMMUNOLOGICAL RESPONSE OF MICE WITH MENINGEAL LEUKEMIA (L1210) TO CHALLENGE WITH AN ANTIFOLIC-RESISTANT VARIANT.
    CHIRIGOS MA; THOMAS LB; HUMPHREYS SR; GLYNN JP; GOLDIN A
    Cancer Res; 1964 Apr; 24():409-15. PubMed ID: 14147814
    [No Abstract]   [Full Text] [Related]  

  • 9. Incorporation of formate-C-14 in normal and leukemic mice during extended treatment with amethopterin and 3',5'-dichloramethopterin.
    SCHRECKER AW; MEAD JA; GOLDIN A
    Cancer Res; 1962 Jan; 22():15-20. PubMed ID: 13909245
    [No Abstract]   [Full Text] [Related]  

  • 10. An investigation into the synergistic antileukemic action of amethopterin and 6-mercaptopurine in mice.
    GOLDIN A; VENDITTI JM; HUMPHREYS SR; DENNIS D; MANTEL N; GREENHOUSE SW
    J Natl Cancer Inst; 1955 Aug; 16(1):129-38. PubMed ID: 13243117
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of amethopterin resistance in leukemia. I. Effects of weak folic acid antagonists on mouse leukemias.
    BURCHENAL JH; JOHNSTON SF; WARING GB
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):348-51. PubMed ID: 14892015
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin.
    GOLDIN A; HUMPHREYS SR; MANTEL N; VENDITTI JM
    J Natl Cancer Inst; 1956 Aug; 17(2):203-12. PubMed ID: 13357939
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of amethopterin and 3',5'-dichloroamethopterin in sensitive and resistant sublines of the Ehrlich carcinoma.
    SARTORELLI AC; BOOTH BA
    Cancer Res; 1962 Jan; 22():94-101. PubMed ID: 14497280
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of growth of amethopterinsensitive and amethopterin-resistant pairs of lymphocytic neoplasms by dietary folic-acid deficiency in mice.
    POTTER M; BRIGGS GM
    J Natl Cancer Inst; 1962 Feb; 28():341-51. PubMed ID: 14488297
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells.
    FISCHER GA
    Biochem Pharmacol; 1961 Jul; 7():75-7. PubMed ID: 13699838
    [No Abstract]   [Full Text] [Related]  

  • 16. CLINICAL STUDIES OF DICHLOROMETHOTREXATE (NSC 29630).
    FREI E; SPURR CL; BRINDLEY CO; SELAWRY O; HOLLAND JF; RALL DP; WASSERMAN LR; HOOGSTRATEN B; SHNIDER BI; MCINTYRE OR; MATTHEWS LB; MILLER SP
    Clin Pharmacol Ther; 1965; 6():160-71. PubMed ID: 14288185
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromatographic studies of purine metabolism. III. Effects of A-methopterin on formate-C14 utilization in mice bearing susceptible and dependent L1210 leukemia.
    TOMISEK AJ; KELLY HJ; REID MR; SKIPPER HE
    Arch Biochem Biophys; 1958 Nov; 78(1):83-94. PubMed ID: 13595905
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical changes in the tissues of leukemic mice. II. The effects of amethopterin.
    CERECEDO LR; BRESNICK E
    Exp Med Surg; 1961; 19():251-7. PubMed ID: 13877688
    [No Abstract]   [Full Text] [Related]  

  • 19. [Investigation on the effect of folic acid antagonist 4-aminopteroyl-aminoadipic acid on the development of transplanted leukosis in mice].
    KIRSANOVA VA; VODOLAZSKAIA NA
    Vopr Onkol; 1955; 1(4):59-64. PubMed ID: 13299820
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of amethopterin on tumor growth and liver glutathione levels of mice bearing lymphocytic leukemias.
    LAW LW; SHACTER B
    J Natl Cancer Inst; 1956 Sep; 17(3):391-8. PubMed ID: 13367809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.